MYGN MYRIAD GENETICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about MYRIAD GENETICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 13 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 14 reports on MYGN from 10 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: SVB Leerink raised its target from $5.00 (set 31 Jul 2026) to $8.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Craig-Hallum | John Wilkin | Buy | 2 Oct 2026 | 8.00 USD |
| Craig-Hallum | William B Bonello | Buy | 11 Aug 2026 | 8.00 USD |
| Guggenheim | Subbu Nambi | Hold | 4 Aug 2026 | — |
| Jefferies | Tycho W Peterson | Sell | 21 Aug 2026 | 2.50 USD |
| Leerink Partners | Puneet Souda | Hold | 31 Jul 2026 | 5.00 USD |
| Piper Sandler | David Westenberg | Hold | 20 Oct 2026 | 5.00 USD |
| Stephens | Mason Carrico | Hold | 18 Aug 2026 | 3.00 USD |
| TD Cowen | Kyle Boucher | Hold | 13 Oct 2026 | 4.50 USD |
| UBS | Doug Schenkel | Hold | 9 Sep 2026 | Conflicting reports · excluded |
| UBS | Lu Li | Hold | 9 Sep 2026 | 3.60 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Oct 2026 | — |
| Wells Fargo | Evan Stampler | — | 20 Oct 2026 | 4.50 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Oct 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:06 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.